Hosted on MSN16h
Naymote Report Slams Boakai Administration for Slow Progress in First Year
A new report released by Naymote Partners for Democratic Development has raised serious concerns over the slow pace of President Joseph Nyuma Boakai's administration in delivering on its promises. The ...
News Medical17h
Scottish Medicines Consortium approves Libtayo as second-line treatment for advanced cervical cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Mineralys outlines pivotal trial timelines for lorundrostat in hypertension
CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...
"It's like recording sounds across time": How Yumi Matsutoya used AI to turn back the clock when crafting her new album
One of Japan's most celebrated singers harnessed Dreamtonics' vocal processing to create a new voice which transcends time ...
PharmiWeb4d
Libtayo® (cemiplimab) Now Available on the National Health Service in Scotland for Patients with Recurrent or Metastatic Cervical Cancer
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...